The British Medical Journal (BMJ) recently published an article titled ‘Ghostwriting: the importance of definition and its place in contemporary drug marketing’. In the article, the author, Alastair Matheson, describes … Continue Reading Defining ghostwriting: ISMPP and GAPP respond to controversial BMJ article
A study by Vera-Badillo et al., recently published in the European Journal of Cancer concluded that inappropriate authorship is prevalent in publications reporting systemic cancer therapy. Two-thirds (40/61) of evaluable … Continue Reading Is inappropriate authorship prevalent in oncology trial reporting?
The push for transparency of clinical trial data has gathered momentum over recent years. The World Health Organization (WHO) has called for journal submission of trial results within one year … Continue Reading Is the timely publication of clinical trial results a reality?
Many organisations and journals advocate the sharing of individual patient-level clinical data to facilitate additional analyses and increase transparency around clinical trials. Are the current strategies for facilitating data sharing … Continue Reading Improving data sharing for the advancement of research
In the scientific community a big problem may arise when different labs cannot reproduce certain experiments. In this lecture, Dr. Silberberg focuses on two of the components that contribute to … Continue Reading [VIDEO] Reproducibility of experiments in biomedical sciences
The Council of Science Editors annual meeting, held in Denver last month saw 450 professionals converge to present, discuss and debate issues such as scientific misconduct, data-sharing and potential strategies … Continue Reading Communicating the facts: highlights from the Council of Science Editors annual meeting
Planning is a fundamental part of the research process. For clinical trials, this takes the form of a detailed study protocol, which provides precise information about the study objectives, design, … Continue Reading Study protocols to be published alongside trial reports in Annals of Internal Medicine
A recent blog from Nature highlights some of the current issues facing successful clinical-trial data sharing, including resource shortages, insufficient government regulation and incompatible reporting. Vivli, a new data sharing … Continue Reading The road to successful data sharing
The registration of clinical trials on public platforms such as clinicaltrials.gov has become commonplace in recent years and is now a prerequisite for the publication of clinical data in many … Continue Reading Access all publications related to a clinical trial at a click of a button
Data sharing must become routine argue Richard Smith and Ian Roberts in a recent opinion article published on F1000Research. They acknowledge that researchers are incentivised to publish papers rather than … Continue Reading Why do researchers refuse to share their data?
In a recent article published in Research Integrity and Peer Review, Dunn et al argue the benefits of having a fully-accessible, central database for researcher conflicts of interest. While improvements … Continue Reading Researchers argue for a central conflicts of interest database
Over 500 journals have endorsed the Transparency and Openness Promotion (TOP) guidelines, a new scheme aiming to improve the transparency and reproducibility of published research. The guidelines consist of eight … Continue Reading How to simplify manuscript submission
As a prerequisite for publication of research, the International Committee of Medical Journal Editors (ICMJE) requires registration of clinical trials and recommends this to editors of medical journals. Similarly, provision … Continue Reading Retrospective vs. prospective registration of clinical trials – what is the norm?
In a recent blog Dr Ben Goldacre, from Oxford University DataLab, describes the concept of OpenTrials, an open platform for locating and sharing all freely available data and documents from … Continue Reading OpenTrials: all clinical trial data in one place
In a recent article published by the Journal of the American Medical Association (JAMA) Bauchner et al, reflect on the ethical obligations and scientific necessity of clinical trial data sharing. … Continue Reading The ethical obligation of data sharing
Following the publication of a controversial editorial in the New England Journal of Medicine, the Health Affairs Blog recently took a closer look at the risks and benefits of sharing … Continue Reading How do we ensure that data sharing benefits all?